You can buy and sell Esperion Therapeutics (ESPR) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details.

Esperion Therapeutics, ordinary share. US29664W1053, ESPR, 0ET · 1 M · 3 M · 6 M · 1 Y · 3 Y.

Esprit Holdings is Other stocks mentioned: NVS, VBIV. 2 months ago - Benzinga. ESPERION | Stock Information. ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices. 2021-02-23 · Esperion Therapeutics' stock was trading at $42.93 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ESPR stock has decreased by 39.6% and is now trading at $25.93.

Esperion therapeutics stock

What price target have analysts set for ESPR? Such requests are fraud schemes and are not authorized by ESPERION. If you are contacted by a scammer, please do not respond to any requests for banking information or personally identifiable information and contact your local authority or file a report of the potential e-scam to the FBI’s Internet Crime Complaint Center at www.ic3.gov . Esperion Therapeutics Inc. NASDAQ Updated Apr 8, 2021 8:39 PM ESPR 28.22 0.66 (2.40%).

Company profile page for Esperion Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information

2008-06-27 · Current trading price (as of last close) is $28.92 ( a little over the 52 week low) and the the analysts mentioned in my various trading/research accounts have price targets from $35 to $150, with an average of $74. Different ranking services have this as a Buy or Strong Buy. ESPERION is The Lipid Management Company, pursuing the research and development of novel lipid-lowering therapies for everybody. 2021-02-03 · In Q3 2020, the number of bullish hedge fund positions on Esperion Therapeutics Inc. (NASDAQ:ESPR) stock decreased by about 11% from the previous quarter (see the chart here), so a number of other Esperion Therapeutics Stock - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2021. Esperion Therapeutics, Inc is a biotechnology business based in the US. Esperion Therapeutics shares (ESPR) are listed on the NASDAQ and all prices are listed in US Dollars.

Esperion Therapeutics, Inc. is a pharmaceutical company. It engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein

Their average twelve-month price target is $50.60, predicting that the stock has a possible upside of 95.59%. The high price target for ESPR is $134.00 and the low price target for ESPR is $24.00. 2021-04-06 · Esperion Therapeutics Inc. company facts, information and financial ratios from MarketWatch. Free-Float. 92,0%. More Financials.

Esperion Therapeutics (Esperion Therapeutics: ESPR) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, Esperion Therapeutics, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page ESPR stock forecast.
Rituals skovde

Esperion Therapeutics Inc (ESPR) Q3 Esperion has two approved drugs — Nexletol (bempedoic acid [180mg] and Nexlizet (bempedoic acid [180mg]/ ezetimibe [10mg] combination pill) — in its portfolio, which were approved in February 2020 Esperion Therapeutics Inc. NASDAQ Updated Apr 8, 2021 8:39 PM ESPR 28.22 0.66 (2.40%). Post-Market 0.00 (0.00%) As of 1:13 p.m. EST, Esperion Therapeutics' stock is down by 11.4%, after dropping by as much as 12.5% earlier in the day. So what Esperion Therapeutics thinks its revenue for the fourth quarter

That translates to a mean rating of 2.4.
Polan och pyret

Esperion Therapeutics. stock was originally listed at a price of $14.50 in Jun 26, 2013. If you had invested in Esperion Therapeutics stock at $14.50, your return over the last 7 years would have been 98%, for an annualized return of 10.25%.

2021-04-06 2020-06-05 Esperion Therapeutics Inc Stock Forecast. Over the next 52 weeks, Esperion Therapeutics Inc has on average historically risen by 103.3 % based on the past 7 years of stock performance. Esperion Therapeutics Inc has risen higher in 3 of those 7 years over the subsequent 52 week period, corresponding to a historical accuracy of 50 % Find real-time ESPR - Esperion Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

Privatisering sjukvård fördelar

2021-03-01

The high price target for ESPR is $134.00 and the low price target for ESPR is $24.00.

Find real-time ESPR - Esperion Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. Esperion Therapeutics Inc stock news This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. The Esperion Therapeutics 52-week low stock price is 23.90, which is 13.9% below the current share price. The average Esperion Therapeutics stock price for the last 52 weeks is 35.25 .

Dive deeper with interactive charts and top stories of ESPERION THERAPEUTICS, INC.. It might with Esperion Therapeutics . The company sports one of the highest short interests in the entire stock market at more than 43%; that appears to be among the top 10 most-shorted stock. 2021-04-09 · At $61, the average analyst price target indicates 77% upside potential. (See Esperion Therapeutics stock analysis on TipRanks) Concluding Thoughts Esperion Therapeutics is a classic case of a 2021-04-10 · Find the latest Institutional Holdings data for Esperion Therapeutics, Inc. Common Stock (ESPR) at Nasdaq.com.